These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19853220)

  • 21. Early prediction of medication refractoriness in children with idiopathic epilepsy based on scalp EEG analysis.
    Lin LC; Ouyang CS; Chiang CT; Yang RC; Wu RC; Wu HC
    Int J Neural Syst; 2014 Nov; 24(7):1450023. PubMed ID: 25164248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opportunity gained, opportunity lost: treating pharmacoresistant epilepsy in children.
    Donner EJ
    Epilepsia; 2013 May; 54 Suppl 2():16-8. PubMed ID: 23646965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a place for surgical treatment of nonpharmacoresistant epilepsy?
    Steinhoff BJ; Staack AM
    Epilepsy Behav; 2019 Feb; 91():4-8. PubMed ID: 29960857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacoresistant epilepsy - epidemiology and current studies].
    Pierzchala K
    Neurol Neurochir Pol; 2010; 44(3):285-90. PubMed ID: 20648993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early identification of refractory epilepsy.
    Kwan P; Brodie MJ
    N Engl J Med; 2000 Feb; 342(5):314-9. PubMed ID: 10660394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of drug-resistant epilepsy.
    Löscher W
    Novartis Found Symp; 2002; 243():149-59; discussion 159-66, 180-5. PubMed ID: 11990774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy.
    Bauer J; Buchmüller L; Reuber M; Burr W
    Acta Neurol Scand; 2008 Jan; 117(1):55-9. PubMed ID: 17961196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurovascular Drug Biotransformation Machinery in Focal Human Epilepsies: Brain CYP3A4 Correlates with Seizure Frequency and Antiepileptic Drug Therapy.
    Williams S; Hossain M; Ferguson L; Busch RM; Marchi N; Gonzalez-Martinez J; Perucca E; Najm IM; Ghosh C
    Mol Neurobiol; 2019 Dec; 56(12):8392-8407. PubMed ID: 31243719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High seizure frequency prior to antiepileptic treatment is a predictor of pharmacoresistant epilepsy in a rat model of temporal lobe epilepsy.
    Löscher W; Brandt C
    Epilepsia; 2010 Jan; 51(1):89-97. PubMed ID: 19563347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible interplay between the theories of pharmacoresistant epilepsy.
    Juvale IIA; Che Has AT
    Eur J Neurosci; 2021 Mar; 53(6):1998-2026. PubMed ID: 33306252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it.
    Łukawski K; Czuczwar SJ
    Expert Opin Drug Metab Toxicol; 2021 Sep; 17(9):1075-1090. PubMed ID: 34310255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction between electrical modulation of the brain and pharmacotherapy to control pharmacoresistant epilepsy.
    Rocha L
    Pharmacol Ther; 2013 May; 138(2):211-28. PubMed ID: 23353099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Animal models of intractable epilepsy.
    Löscher W
    Prog Neurobiol; 1997 Oct; 53(2):239-58. PubMed ID: 9364612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intractable epilepsy in adults.
    Leppik IE
    Adv Exp Med Biol; 2002; 497():1-7. PubMed ID: 11993725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy.
    Pohlmann-Eden B; Crocker CE; Schmidt MH
    Epilepsia; 2013 May; 54 Suppl 2():75-9. PubMed ID: 23646977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Refractory seizures: try additional antiepileptic drugs (after two have failed) or go directly to early surgery evaluation?
    Kwan P; Sperling MR
    Epilepsia; 2009 Sep; 50 Suppl 8():57-62. PubMed ID: 19702735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Outcomes of surgical treatment of patients with pharmacoresistant epilepsy].
    Krylov VV; Guekht AB; Trifonov IS; Lebedeva AV; Kaimovsky IL; Sinkin MV; Grigorieva EV; Grishkina MN; Shyshkina LV; Kochetkova OO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(9. Vyp. 2):13-18. PubMed ID: 28005041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of drug-resistant epilepsy].
    Loizon M; Rheims S
    Presse Med; 2018 Mar; 47(3):234-242. PubMed ID: 29525516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments.
    Xu C; Gong Y; Wang Y; Chen Z
    Pharmacol Ther; 2022 May; 233():108026. PubMed ID: 34718071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In search of models of pharmacoresistant epilepsy.
    Wahab A; Albus K; Gabriel S; Heinemann U
    Epilepsia; 2010 Jul; 51 Suppl 3():154-9. PubMed ID: 20618423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.